Polymerase Chain Reaction Molecular Diagnostics market size is expected to reach $14.65 by 2030 at 8.4%, driven by rising prevalence of infectious diseases.
Read More
Polymerase Chain Reaction (PCR) Technologies market size is expected to reach $26.8 billion by 2030 at 10.2%, driven by increasing prevalence of infectious diseases.
Read More
Polymerase Chain Reaction (PCR) market size is expected to reach $19.62 billion by 2030 at 9%, driven by rising demand for personalized medicine.
Read More
The polygenic risk score services market is projected to reach $3.11 by 2030, growing at 16.4% CAGR, driven by AI, genomics, and preventive healthcare solutions.
Read More
Polycystic ovarian syndrome treatment market to reach $7.28 billion by 2030 at 7.8% cagr, driven by rising genetic and hormonal disorders.
Read More
Poly ADP-Ribose Polymerase (PARP) Inhibitor market size is expected to reach $14.93 billion by 2030 at 9.7%, driven by increasing prevalence of ovarian cancer.
Read More
Global Pollen Allergy market size is expected to reach $10.94 billion by 2030 at 7.8%, prevalence of allergic rhinitis driving increased demand for pollen allergens
Read More
Global Point-of-Care Glucose Testing market size is expected to reach $6.3.95 billion by 2030 at 6.3%, the surge in diabetes propels point-of-care glucose testing market growth
Read More
Point-of-care data management software market to reach $3.78 bn by 2030 at 12.9% CAGR, driven by adoption of electronic health records.
Read More
Point of Care Ultrasound market size is expected to reach $6.55 billion by 2030 at 7.6%, driven by rising prevalence of chronic diseases.
Read More